Raffaele Giusti, Medical director at Azienda Ospedaliera Sant’Andrea, shared on X:
“MARIPOSA OS data at ELCC25. While the combination offers a statistically significant OS advantage, the absolute clinical benefit is disappointingly modest.
Should more always mean better? Or should we be striving for smarter, not just stronger, strategies?”
